Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; magnesium stearate; lactose monohydrate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - early breast cancer. adjuvant treatment of early breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease. advanced breast cancer. first line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone-receptor-positive disease. . treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with oestrogen-receptor-negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; hyprolose; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; titanium dioxide; hypromellose; macrogol 4000 - early breast cancer: adjuvant treatment of early breast cancer in post-menopausal women with estrogen/progesterone receptor positive disease. advanced breast cancer: first line treatment of advanced breast cancer in post-menopausal women with estrogen/progesterone receptor positive disease. treatment of advanced breast cancer in post-menopausal women with disease progression following tamoxifen therapy. patients with estrogen-receptor-negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: sodium starch glycollate; titanium dioxide; lactose monohydrate; magnesium stearate; hydrogenated cottonseed oil; hypromellose; macrogol 6000; pregelatinised maize starch; povidone - early breast cancer. adjuvant treatment of early breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. advanced breast cancer. first line treatment of advanced breast cancer in postmenopausal women with oestrogen/progesterone receptor positive disease. treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - anastrozole, quantity: 1 mg - tablet, film coated - excipient ingredients: magnesium stearate; povidone; sodium starch glycollate; lactose monohydrate; titanium dioxide; hypromellose; macrogol 400 - early breast cancer. adjuvant treatment of early breast cancer in postmenopausal women with oestrogen/ progesterone receptor positive disease.. advanced breast cancer. first line treatment of advanced breast cancer in postmenopausal women with oestrogen/ progesterone receptor positive disease.. treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. patients with oestrogen receptor negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - anastrozole -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - anastrozole -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - anastrozole -

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

cristers - anastrozole 1 mg - comprimé - 1 mg - pour un comprimé > anastrozole 1 mg - inhibiteurs enzymatiques - anastrozole cristers contient une substance appelée anastrozole. il appartient à un groupe de médicaments appelés « inhibiteurs de l'aromatase ». anastrozole cristers est utilisé dans le traitement du cancer du sein de la femme ménopausée.anastrozole cristers agit en diminuant la quantité d'une hormone appelée estrogène que votre corps fabrique. il effectue cela en bloquant une substance naturelle (un enzyme) de votre corps appelé « aromatase».

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - anastrozole 1mg - film coated tablet - 1 mg - active: anastrozole 1mg excipient: hypromellose lactose monohydrate magnesium stearate opadry white y-1-7000 povidone sodium starch glycolate - treatment of advanced breast cancer in post-menopausal women.

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

accord healthcare france sas - anastrozole 1 - comprimé - 1,00 mg - pour un comprimé > anastrozole 1,00 mg - inhibiteurs enzymatiques, c ode atc l02b g03 - classe pharmacothérapeutique - code atc : inhibiteurs enzymatiques, code atc : l02b g03anastrozole accord contient une substance appelée anastrozole. il appartient à un groupe de médicaments appelés « inhibiteurs de l’aromatase ». anastrozole accord est utilisé dans le traitement du cancer du sein de la femme ménopausée.anastrozole accord agit en diminuant la quantité d’une hormone appelée estrogène que votre corps fabrique. il effectue cela en bloquant une substance naturelle (un enzyme) de votre corps appelé « aromatase ».